abstract |
The present invention relates to a composition for the prevention or treatment of metabolic diseases, which comprises Bactheridase escidifensans as an active ingredient. The present invention also relates to a composition for inhibiting lipid oxidation or DPP-4, which comprises Bacteroides acidifaciens as an active ingredient. Further, the present invention relates to a transformant showing a dry phenotype in which Atg7 gene is deleted in dendritic cells. |